Dr Griveas and Nephrology Department of 417 NIMTS published recently their experience with Covid- 19 patients under hemodialysis

Select the links below to open the articles and read the publications:

• COVID-19 infection in patients receiving hemodialysis in Athens: Findings, experience, and outcome from a single Dialysis Unit
• Soluble urokinase plasminogen activator receptor and its complicated role in hemodialysis (HD) patients with Covid-19 infection
• IgM and IgG antibody response to SARS-CoV-2 Infection and Viral RNA Persistence in hospitalized chronic kidney disease patients under Hemodialysis (HD)